阿尔多在慢性病中的作用

相关实验视频

Updated: Jan 16, 2026

05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.5K

Paula Polenus¹, Ana Đuran², Sandra Karanović Štambuk^1,3

¹School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.

Biomedicines

|September 27, 2025

概括

矿物质皮质类受体过度活化驱动慢性病的进展. 针对阿尔多素的新型疗法,如芬,在减少残留风险和改善患者的治疗结果方面表现有前途.

科学领域:

腎臟病學 (nephrology) 是一種醫學專業.
心脏病学心脏病学
内分泌学在内分泌学.

背景情况:

慢性病 (CKD) 构成了全球健康负担,具有显著的发病率和死亡率.
现有的治疗方法,如RAS抑制剂和SGLT2抑制剂,留下了相当大的残留风险.
阿尔多激素过度激活是CKD进展的关键因素,导致炎和纤维化.

研究的目的:

综述阿尔多斯特在CKD中的病理生理学.
探索新兴的治疗策略,以矿物质皮质醇受体通路为目标.
为解决对慢性病患者残留风险管理的未满足需求.

主要方法:

综述阿尔多素合成和分泌的生理调节.
在RAS阻塞下对阿尔多激素突破的分析.
评估阿尔多斯特中介损伤的机制.
评估新型治疗药物,包括非类固醇MRA和阿尔多氨酸合成酶抑制剂.

主要成果:

芬龙是一种新的非类固醇MRA,在减少脏和心血管结果方面显示出更好的安全性和有效性.
阿尔多氨酸合成酶抑制剂提供一种上游方法来降低阿尔多氨酸的产量.
这些药物显示出减轻CKD残留心血管和风险的潜力.

结论:

向阿尔多激素过度激活对于控制CKD进展至关重要.
新型治疗药物,如费内伦和阿尔多氨酸合成酶抑制剂,代表了有前途的战略.
这些进展可能通过减少残留风险显著改善CKD患者的长期结果.

关键词:

阿尔多斯氨酸是一种阿尔多斯氨酸.阿尔多斯特合成酶抑制剂慢性脏疾病慢性脏疾病矿物质皮质类受体的受体.非类固醇矿物质皮质类受体对抗剂

相关概念视频

01:25

Chronic Kidney Disease I: Introduction

565

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...

565

01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

2.2K

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...

2.2K

01:18

Chronic Kidney Disease IV: Nursing Management

321

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...

321

01:28

Chronic Kidney Disease III: Interprofessional Care

344

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...

344

01:13

Introduction to Urinary System

8.5K

The urinary system consists of two kidneys, two ureters, the urinary bladder, and the urethra.
The kidneys are bean-shaped organs located in the retroperitoneal space, on either side of the vertebral column, between the T12 and L3 vertebrae. They are partially protected by the rib cage and surrounded by perirenal fat, which provides cushioning. They are responsible for urine formation and play critical roles in regulating blood pressure, electrolyte levels, and hormone production. The ureters...

8.5K

01:33

Hormonal Regulation

35.7K

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.